Institutional investors purchased a net $10.2 million shares of GSK during the quarter ended September 2015, and now own 9.25% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EQUITY INVESTMENT CORP. Bought 800.6 Thousand shares of GlaxoSmithKline
HIGHSTREET ASSET MANAGEMENT, INC... Bought 128.0 Thousand shares of GlaxoSmithKline
HAMLIN CAPITAL MANAGEMENT LLC Bought 109.0 Thousand shares of GlaxoSmithKline